Altium Capital Management’s Alimera Sciences ALIM Stock Holding History

Altium Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,150,000	Closed	-$12M	–	99
2024 Q2	$12M	Sell	2,150,000 -400,000	-16%	-$1.42M	4.88%	7
2024 Q1	$9.95M	Sell	2,550,000 -110,000	-4%	-$419K	3.94%	7
2023 Q4	$11.5M	Sell	2,660,000 -274,108	-9%	-$926K	7.8%	2
2023 Q3	$9.1M	Buy	+2,934,108	New	+$9.7M	4.74%	8

Altium Capital Management's ALIM Position: Q3 2024 in Review

Altium Capital Management sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 2,150,000 shares — an estimated $12M sold.

Altium Capital Management first reported a position in ALIM in Q3 2023 and held it in 4 quarters. The position peaked at $12M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

Altium Capital Management reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
Altium Capital Management sold 2,150,000 Alimera Sciences shares in Q3 2024, an estimated $12M.
Altium Capital Management first reported a position in Alimera Sciences in Q3 2023 and held it in 4 quarters.
Altium Capital Management's Alimera Sciences position peaked at $12M in Q2 2024.
0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Altium Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.